ENTPD3 Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | O75355 |
---|---|
Clone Names | 91009018 |
Gene ID | 956 |
---|---|
Other Names | Ectonucleoside triphosphate diphosphohydrolase 3, NTPDase 3, CD39 antigen-like 3, Ecto-ATP diphosphohydrolase 3, Ecto-ATPDase 3, Ecto-ATPase 3, Ecto-apyrase 3, HB6, ENTPD3, CD39L3 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | ENTPD3 |
---|---|
Synonyms | CD39L3 {ECO:0000303|PubMed:9676430} |
Function | Has a threefold preference for the hydrolysis of ATP over ADP. |
Cellular Location | Cell membrane {ECO:0000250|UniProtKB:Q8BFW6}; Multi-pass membrane protein |
Tissue Location | Expressed in adult brain, pancreas, spleen and prostate (PubMed:9676430). Moderate or low expression is seen in most tissues (PubMed:9676430). Not expressed in liver and peripheral blood leukocytes (PubMed:9676430). |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
ENTPD3 is similar to E-type nucleotidases (NTPases).NTPases, such as CD39, mediate catabolism of extracellularnucleotides. ENTPD3 contains 4 apyrase-conserved regions which ischaracteristic of NTPases.
References
Fausther, M., et al. Am. J. Physiol. Lung Cell Mol. Physiol. 298 (6), L804-L818 (2010) :Gaddie, K.J., et al. Biochemistry 48(40):9437-9447(2009)Munkonda, M.N., et al. FEBS J. 276(2):479-496(2009)Munkonda, M.N., et al. Biochem. Pharmacol. 74(10):1524-1534(2007)Ivanenkov, V.V., et al. Biochemistry 44(25):8998-9012(2005)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.